Found: 19
Select item for more details and to access through your institution.
Protective and pathological roles of regulatory immune cells in human cytomegalovirus infection following hematopoietic stem cell transplantation.
- Published in:
- Reviews in Medical Virology, 2022, v. 32, n. 4, p. 1, doi. 10.1002/rmv.2319
- By:
- Publication type:
- Article
Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Induced Pluripotent Stem Cells (iPSCs) Provide a Potentially Unlimited T Cell Source for CAR-T Cell Development and Off-the-Shelf Products.
- Published in:
- Pharmaceutical Research, 2021, v. 38, n. 6, p. 931, doi. 10.1007/s11095-021-03067-z
- By:
- Publication type:
- Article
Hurdles to breakthrough in CAR T cell therapy of solid tumors.
- Published in:
- Stem Cell Research & Therapy, 2022, v. 13, n. 1, p. 1, doi. 10.1186/s13287-022-02819-x
- By:
- Publication type:
- Article
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02510-7
- By:
- Publication type:
- Article
CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02462-y
- By:
- Publication type:
- Article
Reconstructing the cell–cell interaction network among mouse immune cells.
- Published in:
- Biotechnology & Bioengineering, 2023, v. 120, n. 9, p. 2756, doi. 10.1002/bit.28431
- By:
- Publication type:
- Article
Strengthening the CAR‐T cell therapeutic application using CRISPR/Cas9 technology.
- Published in:
- Biotechnology & Bioengineering, 2021, v. 118, n. 10, p. 3691, doi. 10.1002/bit.27882
- By:
- Publication type:
- Article
CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth.
- Published in:
- Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.01149
- By:
- Publication type:
- Article
Overcoming the UCB HSCs –Derived NK cells Dysfunction through Harnessing RAS/MAPK, IGF-1R and TGF-β Signaling Pathways.
- Published in:
- Cancer Cell International, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12935-021-01983-z
- By:
- Publication type:
- Article
CAR-NK Cell: A New Paradigm in Tumor Immunotherapy.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.673276
- By:
- Publication type:
- Article
Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.699746
- By:
- Publication type:
- Article
A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.681984
- By:
- Publication type:
- Article
Harnessing Mechanisms of Immune Tolerance to Improve Outcomes in Solid Organ Transplantation: A Review.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.688460
- By:
- Publication type:
- Article
Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Engineering the Bridge between Innate and Adaptive Immunity for Cancer Immunotherapy: Focus on γδ T and NK Cells.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 8, p. 1757, doi. 10.3390/cells9081757
- By:
- Publication type:
- Article
Overcoming Immunological Resistance Enhances the Efficacy of a Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic Ductal Adenocarcinoma.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 9, p. 1070, doi. 10.3390/cells8091070
- By:
- Publication type:
- Article
CAR‐NK cell in cancer immunotherapy; A promising frontier.
- Published in:
- Cancer Science, 2021, v. 112, n. 9, p. 3427, doi. 10.1111/cas.14993
- By:
- Publication type:
- Article
Delivery of miRNA-126 through folic acid-targeted biocompatible polymeric nanoparticles for effective lung cancer therapy.
- Published in:
- Journal of Bioactive & Compatible Polymers, 2022, v. 37, n. 3, p. 168, doi. 10.1177/08839115221095152
- By:
- Publication type:
- Article